Seres Therapeutics Stock Quote MCRB - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

1.15

Bid

1.15

Ask

1.16

Volume

4,464,739

1.08 Day's Range 1.19

0.54 52 Week Range 6.26

Market Cap

172.151M

Previous Close

1.11

Open

1.11

Last Trade

176

1.15

(formt)

Last Trade Time

Financial Volume

$ 5,054,888

VWAP

1.1322

Average Volume (3m)

4,487,925

Shares Outstanding

151,009,462

Dividend Yield

PE Ratio

-1.51

Earnings Per Share (EPS)

-0.75

Revenue

126.33M

Net Profit

-113.72M

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the func... Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.serestherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Seres Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MCRB. The last closing price for Seres Therapeutics was $1.11. Over the last year, Seres Therapeutics shares have traded in a share price range of $ 0.54 to $ 6.26.

Seres Therapeutics currently has 151,009,462 shares outstanding. The market capitalization of Seres Therapeutics is $172.15 million. Seres Therapeutics has a price to earnings ratio (PE ratio) of -1.51.

Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT

Clinical data readout expected end of Q3 2024 SER-155 and other Seres microbiome therapeutic candidates have potential to expand microbiome therapeutic franchise into additional medically...

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compensation and Talent Committee of...

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”), a leading microbiome therapeutics company, today announced that on March 13, 2024, the Compensation and Talent Committee of...

Form DEF 14A - Other definitive proxy statements

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

VOWST net sales of $10.4 million for the fourth quarter of 2023 and $19.6 million since launch in June through year-end 2023 Significant adoption of VOWST since launch in June 2023 through...

U.S. Futures Dip, Crude Oil Fluctuates

U.S. stock futures indicate a lower opening on Tuesday as investors await the release of new economic data and Target‘s financial results. At 05:28 AM Brasília time, Dow Jones futures...

Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that management will host a conference call and live audio webcast on March 5, 2024 at 8:30...

Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, announced today that Eric Shaff, President and Chief Executive Officer of Seres Therapeutics, will participate...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.4091	55.2166284249	0.7409	1.19	0.74	6561045	0.98246642	CS
4	0.4035	54.0522438044	0.7465	1.19	0.54	5257448	0.77732001	CS
12	0.11	10.5769230769	1.04	1.24	0.54	4487925	0.87548577	CS
26	0.17	17.3469387755	0.98	2.05	0.54	4738099	1.05864574	CS
52	-3.55	-75.5319148936	4.7	6.26	0.54	3716429	2.05285939	CS
156	-20.05	-94.5754716981	21.2	25.055	0.54	2137296	4.36827526	CS
260	-4.21	-78.5447761194	5.36	38.5	0.54	1615265	7.32413442	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BENFBeneficient	$ 6.8001 (254.17%)	31.01M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.18M
SHOTWSafety Shot Inc	$ 0.45 (45.16%)	644
AIPArteris Inc	$ 8.185 (38.03%)	1.11M
RGFReal Good Food Company Inc	$ 0.85 (37.32%)	4.26M
MNDRMobile health Network Solutions	$ 3.33 (-84.91%)	18.76M
NUVOHoldco Nuvo Group DG Ltd	$ 2.00 (-57.54%)	1.04M
SPTSprout Social Inc	$ 28.82 (-40.15%)	13.47M
UNITUniti Group Inc	$ 4.441 (-26.35%)	21.07M
IPDNProfessional Diversity Network Inc	$ 1.29 (-24.12%)	662.59k
AAPLApple Inc	$ 183.38 (5.98%)	163.22M
SQQQProShares UltraPro Short QQQ	$ 11.08 (-5.94%)	154.59M
JAGXJaguar Health Inc	$ 0.3164 (7.91%)	142.47M
NKLANikola Corporation	$ 0.6526 (6.55%)	106.88M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.18M